Full Year Results 

Emis takes its medicine

Emis takes its medicine

We were braced for weaker results from Emis (EMIS) after the healthcare software group advised in January that it had identified a failure to meet certain reporting obligations with NHS Digital. This related to Emis’s web product for GPs. At the time, management anticipated a financial impact “in the order of upper single digits of millions of pounds”. In the event, the provision came in at £11.2m. This should cover potential financial settlement and any costs involved. Operating profit consequently dropped by over a half, from £23.5m to £10.6m, although the figure still came up short of the 2016 comparative when adjusted for exceptional items.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now